These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9068295)

  • 21. Bone marrow transplantation for thalassemia. The USA experience.
    Walters MC; Sullivan KM; O'Reilly RJ; Boulad F; Brockstein J; Blume K; Amylon M; Johnson FL; Klemperer M; Graham-Pole J
    Am J Pediatr Hematol Oncol; 1994 Feb; 16(1):11-7. PubMed ID: 8311166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of AB0-blood group incompatibility on the outcome of recipients of bone marrow transplants from unrelated donors in the Japan Marrow Donor Program.
    Kimura F; Sato K; Kobayashi S; Ikeda T; Sao H; Okamoto S; Miyamura K; Mori S; Akiyama H; Hirokawa M; Ohto H; Ashida H; Motoyoshi K;
    Haematologica; 2008 Nov; 93(11):1686-93. PubMed ID: 18835834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcome of unrelated bone marrow donor searches in 174 children resulting in 45 patients transplanted in the HLA-matched and -mismatched situation.
    Souillet G; Rey S; Bertrand Y; Pujol M; Pondarré C; Bourgeot JP; Raba M; Eljaafari A; Chapuis F; Manel AM; Philippe N; Gebuhrer L
    Bone Marrow Transplant; 2000 Jul; 26(1):31-43. PubMed ID: 10918403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study.
    Güngör T; Teira P; Slatter M; Stussi G; Stepensky P; Moshous D; Vermont C; Ahmad I; Shaw PJ; Telles da Cunha JM; Schlegel PG; Hough R; Fasth A; Kentouche K; Gruhn B; Fernandes JF; Lachance S; Bredius R; Resnick IB; Belohradsky BH; Gennery A; Fischer A; Gaspar HB; Schanz U; Seger R; Rentsch K; Veys P; Haddad E; Albert MH; Hassan M;
    Lancet; 2014 Feb; 383(9915):436-48. PubMed ID: 24161820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term follow-up following bone marrow transplantation for Hunter disease.
    Vellodi A; Young E; Cooper A; Lidchi V; Winchester B; Wraith JE
    J Inherit Metab Dis; 1999 Jun; 22(5):638-48. PubMed ID: 10399096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allogeneic stem cell transplantation using myeloablative and reduced-intensity conditioning in patients with major histocompatibility complex class II deficiency.
    Al-Mousa H; Al-Shammari Z; Al-Ghonaium A; Al-Dhekri H; Al-Muhsen S; Al-Saud B; Arnaout R; Al-Seraihy A; Al-Jefri A; Al-Ahmari A; Ayas M; El-Solh H
    Biol Blood Marrow Transplant; 2010 Jun; 16(6):818-23. PubMed ID: 20079864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study.
    Eapen M; Rubinstein P; Zhang MJ; Stevens C; Kurtzberg J; Scaradavou A; Loberiza FR; Champlin RE; Klein JP; Horowitz MM; Wagner JE
    Lancet; 2007 Jun; 369(9577):1947-54. PubMed ID: 17560447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of morbidity and mortality after marrow transplantation from HLA-genotypically identical siblings and HLA-phenotypically identical unrelated donors.
    Bearman SI; Mori M; Beatty PG; Meyer WG; Buckner CD; Petersen FB; Sanders JE; Anasetti C; Martin P; Appelbaum FR
    Bone Marrow Transplant; 1994 Jan; 13(1):31-5. PubMed ID: 8019451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH).
    Koç ON; Day J; Nieder M; Gerson SL; Lazarus HM; Krivit W
    Bone Marrow Transplant; 2002 Aug; 30(4):215-22. PubMed ID: 12203137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Booster marrow or blood cells for graft failure after allogeneic bone marrow transplantation.
    Remberger M; Ringdén O; Ljungman P; Hägglund H; Winiarski J; Lönnqvist B; Aschan J
    Bone Marrow Transplant; 1998 Jul; 22(1):73-8. PubMed ID: 9678799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psychosocial outcomes of bone marrow transplant for individuals affected by Mucopolysaccharidosis I Hurler Disease: patient social competency.
    Pitt C; Lavery C; Wager N
    Child Care Health Dev; 2009 Mar; 35(2):271-80. PubMed ID: 19228160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Allogeneic bone marrow transplantation in the treatment of (lysosomal) storage diseases].
    Maaswinkel-Mooij PD; Poorthuis BJ; Hoogerbrugge PM; Brouwer OF; Vossen JM
    Ned Tijdschr Geneeskd; 1998 Jan; 142(4):169-74. PubMed ID: 9557021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A preparatory regimen of total body irradiation, busulphan and melphalan for allogeneic bone marrow transplantation in childhood high-risk leukemia and lymphoma.
    Yoshihara T; Naya M; Tsunamoto K; Hojo M; Hibi S; Morimoto A; Todo S; Imashuku S
    Anticancer Res; 2003; 23(2C):1739-42. PubMed ID: 12820450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unrelated bone marrow transplantation for beta-thalassemia patients: The experience of the Italian Bone Marrow Transplant Group.
    La Nasa G; Argiolu F; Giardini C; Pession A; Fagioli F; Caocci G; Vacca A; De Stefano P; Piras E; Ledda A; Piroddi A; Littera R; Nesci S; Locatelli F
    Ann N Y Acad Sci; 2005; 1054():186-95. PubMed ID: 16339665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase II Study of Nonmyeloablative Allogeneic Bone Marrow Transplantation for B Cell Lymphoma with Post-Transplantation Rituximab and Donor Selection Based First on Non-HLA Factors.
    Kanakry JA; Gocke CD; Bolaños-Meade J; Gladstone DE; Swinnen LJ; Blackford AL; Fuchs EJ; Huff CA; Borrello I; Matsui WH; Brodsky RA; Rosner GL; Shanbhag S; Luznik L; Jones RJ; Ambinder RF; Kasamon YL
    Biol Blood Marrow Transplant; 2015 Dec; 21(12):2115-2122. PubMed ID: 26183076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone-marrow transplantation in Hurler's syndrome. Effect on skeletal development.
    Field RE; Buchanan JA; Copplemans MG; Aichroth PM
    J Bone Joint Surg Br; 1994 Nov; 76(6):975-81. PubMed ID: 7983131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early treatment is associated with improved cognition in Hurler syndrome.
    Poe MD; Chagnon SL; Escolar ML
    Ann Neurol; 2014 Nov; 76(5):747-53. PubMed ID: 25103575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cord blood and bone marrow transplantation in inherited metabolic diseases: scientific basis, current status and future directions.
    Prasad VK; Kurtzberg J
    Br J Haematol; 2010 Feb; 148(3):356-72. PubMed ID: 19919654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term outcome of Hurler syndrome following bone marrow transplantation.
    Whitley CB; Belani KG; Chang PN; Summers CG; Blazar BR; Tsai MY; Latchaw RE; Ramsay NK; Kersey JH
    Am J Med Genet; 1993 Apr; 46(2):209-18. PubMed ID: 8484412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Normal intraocular pressure after a bone marrow transplant in glaucoma associated with mucopolysaccharidosis type I-H.
    Christiansen SP; Smith TJ; Henslee-Downey PJ
    Am J Ophthalmol; 1990 Feb; 109(2):230-1. PubMed ID: 2105651
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.